Diabetic neuropathy guidelines nice.
Ideiglenesen le vagy tiltva
Global and regional diabetes prevalence estimates for and projections for and results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract.
Changes in features of diabetes care in Hungary in the period of years — Aims and methods of the database analysis of the National Health Insurance Fund. Az Országos Egészségbiztosítási Pénztár adatbázis-elemzésének célja és módszertana. Decreasing incidence of pharmacologically treated type 2 diabetes in Hungary from to a nationwide cohort study.
Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: a review of the literature. Prevalence of neuropathy in diabetes mellitus. In: Kempler P, Várkonyi T. Neuropathies in clinical practice. Neuropathiák a klinikai gyakorlatban. Risk factors and comorbidities in diabetic neuropathy: an update Rev Diabet Stud.
The effect of cigarette smoking on diabetic peripheral neuropathy: a systematic review and meta-analysis. J Gen Intern Med. Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomes.
Atherosclerosis ; — Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med. Painful diabetic peripheral neuropathy — health care costs cukorbetegség bőrtünetei complications from to Neurol Clin Pract.
Risk factors of dialysis and mortality in type 1 and 2 diabetes.
A nationwide study. Széleskörű hazai felmérés.
Can diabetic polyneuropathy and foot ulcers in patients with type 2 diabetes be accurately identified based on ICD hospital diagnoses and drug prescriptions?
Clin Epidemiol. Annual health insurance treatment cost of diabetic polyneuropathy based on routinely collected financing data.
- [Diagnosis of diabetic cardiac autonomic neuropathy]
Value Health ; 23 Suppl 1 : S Epidemiological disease burden of diabetic polyneuropathy based on diabetic neuropathy guidelines nice collected health insurance claims data. Value Health Reg Issues ; 7: 27— Utilization indicators of balneotherapy in Hungary.
Changes in the health status of the population of Central and Eastern European countries between and Eur J Health Econ. Multicriteria decision analysis in the reimbursement of new medical technologies: real-world experiences from Hungary. Value Health ; — Financial deficits in the health services of the UK and Hungary.
CAN is strongly associated with increased mortality, and in some studies with morbidity of vascular complications, such as stroke, coronary artery disease and myocardial infarction.
Lancet ; — Health insurance pharmaceutical expenditures in Hungary. Further steps in the development of pharmacoeconomics, outcomes research, and health technology assessment in Central and Eastern Diabetic neuropathy guidelines nice, Western Asia, and Africa. Value Health Reg Issues ; 2: — Price competition and reimbursement of biosimilar granulocyte-colony stimulating factor in Hungary.
Expert Rev Pharmacoecon Outcomes Res. Financing of health care services in Hungary. Global, regional, and national age-sex-specific mortality for causes of death in countries and territories, — a systematic analysis for the Global Burden of Disease Study World Health Organization, Geneva,